Mirabegron is contraindicated in patients with: Hypersensitivity to the active substance or to any of the excipients listed in Description.
Severe uncontrolled hypertension defined as systolic blood pressure ≥ 180 mm Hg and/or diastolic blood pressure ≥ 110 mm Hg.